References
- Akah PA, Ekekwe RK (1995): Ethnopharmacology of some Asteraceae family used in Nigerian traditional medicine. Fitoterapia 66: 351–355.
- Anaga AO, Njoku CJ, Ekejiuba ES, Esiaka MN, Asuzu IU (2004): Investigation of the methanolic leaf extract of Costus afer. Ker for pharmacological activities in vivo and in vitro. Phytomedicine 11: 242–248.
- Bailey CJ, Day C (2004): Avandamet: Combined metformin-rosiglitazone treatment for insulin resistance in type 2 diabetes. Int J Clin Pract 58: 867–876.
- Cline GW, Petersen KF, Krssak M, Shen J, Hundal RS, Trajanoski Z, Inzucchi S, Dresner A, Rothman DL, Shulman GI (1999): Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes. New Engl J Med 341: 240–245.
- Erasto P, Adebola PO, Grierson DS, Afolayan AJ (2005): An ethnobotanical study of the plants used for the treatment of diabetes in the Eastern Cape Province, South Africa. Afr J Biotech 4:1458–1460.
- Erasto P, Grierson DS, Afolayan AJ (2006): Bioactive sesquiterpene lactones from the leaves of Vernonia amygdalina. J Ethnopharmacol 106:117–120.
- Huffman MA, Page JE, Sukhdeo MVK, Gotoh S, Kalunde MS, Towers GHN (1996): Leaf swallowing by chimpanzees: A behavioral adaptation for the control of strong nematode infections. Int J Primatol 72: 475–503.
- Igile GO, Oleszek W, Jurzysta M, Burda S, Fanfunso M, Fasanmade AA (1994): Flavonoids from Vernonia amygdalina and their antioxidant activities. J Agric Food Chem 42: 2445–2448.
- Jisaka M, Ohigashi H, Irie R, Huffman MA, Nishida T, Kaji M, Koshimizu K (1992): Bitter steroidal glucosides, vernonioside A1, A2 & A3, and their related B1 from a possible medicinal plant Vernonia amygdalina, used by wild chimpanzees. Tetrahedron 48:625–632.
- Li WL, Zheng HC, Bukuru J, De Kimpe N (2004): Natural medicines used in the traditional Chinese medical system for therapy of diabetes mellitus. J Ethnopharmacol 92: 1–21.
- Maiti R, Jana D, Das UK, Ghosh D (2004): Antidiabetic effect of aqueous extract of seed of Tamarindus indica in streptozotocin- induced diabetic rats. J Ethnopharmacol 92: 85–91.
- Marles RJ, and Farnsworth NR (1995): Antidiabetic plants and their active constituents. Phytomedicine 2: 137–189.
- Mosmann T (1983): Rapid colorimetric assay for cellular growth and survival: Application to prolifereation and cytotoxic assays. J Immunol Methods 65: 55–63.
- Ohigashi H, Jisaka M, Takagaki T, Tada T, Huffman MA, Nishida T, Kaji M, Koshimizu K (1991): Bitter principle and a related steroid glucoside from Vernonia amygdalina, a possible medicinal plant for wild chimpanzees. Agric Biol Chem 55: 1201–1203.
- Schmitz-Peiffer C, Craig DL, Biden TJ (1999): Ceramide generation is sufficient to account for the inhibition of the insulin-stimulated PKB pathway in C2C12 skeletal muscle cells pretreated with palmitate. J Biol Chem 274: 24202–24210.
- Uhegbu FO (2004): Effect of aqueous extract (crude) of leaves of Vernonia amygdalina (Del.) on blood glucose, serum albumin and cholesterol levels in diabetic albino rats. Global J Pure Appl Science 10: 189–194.
- Van de Venter M, Wilson G, Roux S (2006): An optimized method to screen for in vitro antidiabetic activity. Proceedings of the Ninth International Conference on Ethnopharmacology, Nanjing, China, 22–26 August.